Burling Wealth Partners LLC Invests $465,000 in Mettler-Toledo International Inc. (NYSE:MTD)

Burling Wealth Partners LLC bought a new position in shares of Mettler-Toledo International Inc. (NYSE:MTD - Free Report) during the 4th quarter, according to its most recent 13F filing with the SEC. The fund bought 380 shares of the medical instruments supplier's stock, valued at approximately $465,000.

A number of other institutional investors and hedge funds have also made changes to their positions in the stock. JPMorgan Chase & Co. boosted its holdings in Mettler-Toledo International by 14.7% during the third quarter. JPMorgan Chase & Co. now owns 221,799 shares of the medical instruments supplier's stock worth $332,634,000 after buying an additional 28,478 shares in the last quarter. Allworth Financial LP boosted its stake in shares of Mettler-Toledo International by 367.4% during the 4th quarter. Allworth Financial LP now owns 215 shares of the medical instruments supplier's stock worth $285,000 after acquiring an additional 169 shares in the last quarter. Nordea Investment Management AB grew its holdings in shares of Mettler-Toledo International by 29.8% in the 4th quarter. Nordea Investment Management AB now owns 105,823 shares of the medical instruments supplier's stock worth $129,919,000 after acquiring an additional 24,285 shares during the period. Robeco Institutional Asset Management B.V. increased its stake in Mettler-Toledo International by 18.0% in the 4th quarter. Robeco Institutional Asset Management B.V. now owns 34,370 shares of the medical instruments supplier's stock valued at $42,058,000 after purchasing an additional 5,234 shares in the last quarter. Finally, Tokio Marine Asset Management Co. Ltd. raised its holdings in Mettler-Toledo International by 773.3% during the fourth quarter. Tokio Marine Asset Management Co. Ltd. now owns 5,336 shares of the medical instruments supplier's stock worth $6,530,000 after purchasing an additional 4,725 shares during the last quarter. 95.07% of the stock is owned by institutional investors and hedge funds.

Mettler-Toledo International Stock Performance

NYSE MTD traded up $0.16 during mid-day trading on Monday, reaching $1,061.95. 194,880 shares of the stock were exchanged, compared to its average volume of 143,586. The stock has a market capitalization of $22.13 billion, a PE ratio of 26.20, a PEG ratio of 3.30 and a beta of 1.28. Mettler-Toledo International Inc. has a 1-year low of $889.71 and a 1-year high of $1,546.93. The business's fifty day simple moving average is $1,160.03 and its 200 day simple moving average is $1,243.85.

Mettler-Toledo International (NYSE:MTD - Get Free Report) last announced its quarterly earnings data on Thursday, February 13th. The medical instruments supplier reported $12.41 EPS for the quarter, beating analysts' consensus estimates of $11.76 by $0.65. Mettler-Toledo International had a negative return on equity of 591.54% and a net margin of 22.29%. On average, analysts anticipate that Mettler-Toledo International Inc. will post 42.71 EPS for the current year.

Insider Transactions at Mettler-Toledo International

In other Mettler-Toledo International news, insider Christian Magloth sold 790 shares of Mettler-Toledo International stock in a transaction that occurred on Monday, February 24th. The shares were sold at an average price of $1,313.69, for a total transaction of $1,037,815.10. Following the transaction, the insider now directly owns 734 shares of the company's stock, valued at $964,248.46. The trade was a 51.84 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, insider Gerry Keller sold 600 shares of the stock in a transaction on Monday, February 10th. The stock was sold at an average price of $1,351.34, for a total transaction of $810,804.00. Following the completion of the sale, the insider now directly owns 6 shares of the company's stock, valued at $8,108.04. The trade was a 99.01 % decrease in their position. The disclosure for this sale can be found here. Insiders own 1.94% of the company's stock.

Analyst Upgrades and Downgrades

Several analysts have weighed in on MTD shares. Wells Fargo & Company dropped their price target on Mettler-Toledo International from $1,400.00 to $1,125.00 and set an "equal weight" rating for the company in a research report on Thursday, April 17th. Evercore ISI raised their target price on shares of Mettler-Toledo International from $1,450.00 to $1,475.00 and gave the company an "outperform" rating in a report on Monday, February 10th. Citigroup upgraded shares of Mettler-Toledo International from a "neutral" rating to a "buy" rating and set a $1,400.00 target price for the company in a research report on Monday, April 7th. Finally, Robert W. Baird lowered their price target on shares of Mettler-Toledo International from $1,369.00 to $1,034.00 and set a "neutral" rating on the stock in a research report on Tuesday, April 22nd. One investment analyst has rated the stock with a sell rating, five have issued a hold rating and four have given a buy rating to the company's stock. According to data from MarketBeat, the stock currently has an average rating of "Hold" and a consensus target price of $1,304.25.

Mettler-Toledo International Company Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company's laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.